Genetron

Genetron Health Nabs CE Mark for Blood Cancer Residual Disease Test Kit

Genetron Health Q4 Revenues Up 10 Percent

360Dx Top 30 Remains Essentially Flat in February

360Dx Index Rises 20 Percent in 2021

360Dx Index Grows 4 Percent in December Alongside Broader Markets

In Brief This Week: Labcorp, 54gene, Genetron, Thermo Fisher, Aditxt, More

360Dx Index Follows Larger Market Trends, Drops 4 Percent in November

Genetron Health Q3 Revenues up 36 Percent, Firm Announces AstraZeneca MRD Partnership

Genetron Health, NeoGenomics Partner on Oncology Drug Clinical Trials and Testing

Genetron Gets CE Mark for Cancer Genomic Profiling Test

Genetron Health, Fosun Ink Commercialization Deal for Seq-MRD Test in China

Broader Markets Weigh Down Dx Stocks, 360Dx Index Falls 4 Percent in September

Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development

Genetron Health Posts 38 Percent Revenue Increase in Q2

Genetron Health, Yikon Genomics Team up for Reproductive Health Sequencing Assays

360Dx Index Continues Growth in July, Increasing 5 Percent

In Brief This Week: FIND, Sophia Genetics, Dante Labs, BioReference Laboratories, and More

Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project

Genetron Health Receives CE Mark for Lung Cancer Sequencing Assay